Orcivita Sciences And Research Profile
Key Indicators
- Authorised Capital ₹ 1.00 M
as on 04-01-2025
- Paid Up Capital ₹ 30.00 K
as on 04-01-2025
- Company Age 5 Year, 6 Months
- Last Filing with ROC 31 Mar 2024
- Revenue 214.51%
(FY 2022)
- Profit 1010.81%
(FY 2022)
- Ebitda 1145.57%
(FY 2022)
- Net Worth 149.92%
(FY 2022)
- Total Assets 46.24%
(FY 2022)
About Orcivita Sciences And Research
The Company is engaged in the Pharma Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2024. It's a company limited by shares with an authorized capital of Rs 1.00 M and a paid-up capital of Rs 30.00 K , as per Ministry of Corporate Affairs (MCA) records.
Tirna Halder, Tapan Halder, and Lipika Dutta serve as directors at the Company.
- CIN/LLPIN
U73100WB2019PTC232705
- Company No.
232705
- Company Classification
Private Limited Indian Non-Government Company
- Incorporation Date
01 Jul 2019
- Date of AGM
30 Sep 2024
- Date of Balance Sheet
31 Mar 2024
- Listing Status
Unlisted
- ROC Code
Roc Kolkata
Industry
Company Details
- Location
Kolkata, West Bengal, India
- Telephone
- Email Address
- Website
- Social Media-
Who are the key members and board of directors at Orcivita Sciences And Research?
Board Members(3)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Tirna Halder  | Director | 01-Jul-2019 | Current |
| Tapan Halder | Director | 01-Jul-2019 | Current |
| Lipika Dutta | Director | 01-Jul-2019 | Current |
Financial Performance of Orcivita Sciences And Research.
Orcivita Sciences And Research Private Limited, for the financial year ended 2022, experienced significant growth in revenue, with a 214.51% increase. The company also saw a substantial improvement in profitability, with a 1010.81% increase in profit. The company's net worth Soared by an impressive increase of 149.92%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metric |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
| ||||||
| Revenue from Operations |
| ||||||
| Total Assets |
| ||||||
| Profit or Loss |
| ||||||
| Net Worth |
| ||||||
| EBITDA |
|
What is the Ownership and Shareholding Structure of Orcivita Sciences And Research?
In 2021, Orcivita Sciences And Research had a promoter holding of 100.00%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Related Corporates (Common Directorship)
Vitaeternia Clinical Solutions Private LimitedActive 4 years 4 monthsTirna Halder, Tapan Halder and 1 more are mutual person
Charges (Loans)
There are no open charges registered against the company as per our records.
How Many Employees Work at Orcivita Sciences And Research?
Unlock and access historical data on people associated with Orcivita Sciences And Research, such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Orcivita Sciences And Research, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Orcivita Sciences And Research's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
